156 related articles for article (PubMed ID: 31924248)
1. Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis.
Darbà J
Orphanet J Rare Dis; 2020 Jan; 15(1):8. PubMed ID: 31924248
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.
Darbà J; Marsà A
BMJ Open; 2019 Nov; 9(11):e031271. PubMed ID: 31753879
[TBL] [Abstract][Full Text] [Related]
3. Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis.
Darbà J
Clin Drug Investig; 2020 Apr; 40(4):335-341. PubMed ID: 32144652
[TBL] [Abstract][Full Text] [Related]
4. [Infantile spinal atrophy: our experience in the last 25 years].
Madrid Rodríguez A; Martínez Martínez PL; Ramos Fernández JM; Urda Cardona A; Martínez Antón J
An Pediatr (Barc); 2015 Mar; 82(3):159-65. PubMed ID: 25103837
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based study.
Darbà J
J Med Econ; 2019 Oct; 22(10):1025-1029. PubMed ID: 31237171
[No Abstract] [Full Text] [Related]
6. Prevalence of morbidities across the lifespan for adults with spinal muscular atrophy: a retrospective cohort study.
G Whitney D; E Neil Knierbein E; K Daunter A
Orphanet J Rare Dis; 2023 Aug; 18(1):258. PubMed ID: 37653507
[TBL] [Abstract][Full Text] [Related]
7. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
[TBL] [Abstract][Full Text] [Related]
9. Scoliosis in spinal muscular atrophy: is the preoperative magnetic resonance imaging necessary?
Davies NR; Galaretto E; Piantoni L; Remondino RG; Francheri Wilson IA; Monges MS; Frank S; Bersusky ES; Tello CA; Noel MA
Spine Deform; 2020 Oct; 8(5):1089-1091. PubMed ID: 32495206
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Adult Patients With SMA Treated in US Hospital Settings: A Natural History Study in the Premier Healthcare Database.
Johnson NB; Proud C; Wassel CL; Dreyfus J; Cochrane T; Paradis AD
J Neuromuscul Dis; 2021; 8(4):569-578. PubMed ID: 33843692
[TBL] [Abstract][Full Text] [Related]
11. Long-term progression in type II spinal muscular atrophy: A retrospective observational study.
Mercuri E; Lucibello S; Pera MC; Carnicella S; Coratti G; de Sanctis R; Messina S; Mazzone E; Forcina N; Fanelli L; Norcia G; Antonaci L; Frongia AL; Pane M
Neurology; 2019 Sep; 93(13):e1241-e1247. PubMed ID: 31451515
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of spinal muscular atrophy.
Armstrong EP; Malone DC; Yeh WS; Dahl GJ; Lee RL; Sicignano N
J Med Econ; 2016 Aug; 19(8):822-6. PubMed ID: 27264163
[TBL] [Abstract][Full Text] [Related]
13. Opportunities for an early recognition of spinal muscular atrophy in primary care: a nationwide, population-based, study in Italy.
Maggi L; Vita G; Marconi E; Taddeo D; Davì M; Lovato V; Cricelli C; Lapi F
Fam Pract; 2023 Mar; 40(2):308-313. PubMed ID: 35950319
[TBL] [Abstract][Full Text] [Related]
14. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
Darbà J; Marsà A
BMC Cancer; 2019 Dec; 19(1):1226. PubMed ID: 31842791
[TBL] [Abstract][Full Text] [Related]
15. Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).
Mongiovi P; Dilek N; Garland C; Hunter M; Kissel JT; Luebbe E; McDermott MP; Johnson N; Heatwole C
Neurology; 2018 Sep; 91(13):e1206-e1214. PubMed ID: 30143566
[TBL] [Abstract][Full Text] [Related]
16. Spinal muscular atrophy: epidemiology and health burden in children - a Polish national healthcare database perspective before introduction of SMA-specific treatment.
Kostera-Pruszczyk A; Napiórkowski Ł; Szymańska K; Jędrzejczak J; Roszkowski M; Słowiński J; Frączek A; Ryglewicz D; Więckowska B
Neurol Neurochir Pol; 2021; 55(5):479-484. PubMed ID: 34664710
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Primary Posterior Spinal Fusion for Scoliosis in Spinal Muscular Atrophy: Clinical, Radiographic, and Pulmonary Outcomes and Complications.
Holt JB; Dolan LA; Weinstein SL
J Pediatr Orthop; 2017 Dec; 37(8):e505-e511. PubMed ID: 28777284
[TBL] [Abstract][Full Text] [Related]
18. Perioperative complications of scoliosis surgery in patients with Duchenne muscular dystrophy and spinal muscular atrophy, focussing on wound healing disorders.
Burow M; Forst R; Forst J; Hofner B; Fujak A
Int J Neurosci; 2017 Jun; 127(6):479-485. PubMed ID: 27251216
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III.
Chng SY; Wong YQ; Hui JH; Wong HK; Ong HT; Goh DY
J Paediatr Child Health; 2003 Dec; 39(9):673-6. PubMed ID: 14629498
[TBL] [Abstract][Full Text] [Related]
20. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy.
Wijngaarde CA; Brink RC; de Kort FAS; Stam M; Otto LAM; Asselman FL; Bartels B; van Eijk RPA; Sombroek J; Cuppen I; Verhoef M; van den Berg LH; Wadman RI; Castelein RM; van der Pol WL
Neurology; 2019 Jul; 93(2):e149-e158. PubMed ID: 31164393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
